Tender For corrigendum : supply of echs re 12 injection d d - adrenaline tartrate 1 isto 1000 1 ml inj , atropine sulphate 0 point 6 mg 1 ml inj , betamethasone 4 mg 1ml inj , biphasic isophane insulin 50 percent soluble insulin and 50 percent isophane insulin insulin 50 per 50 inj , calcium 9 mg plus calcium gluconate 50 mg inj for iv use 10 ml injection , ceftriaxone 1gm inj , ciprofloxacin 200 mg per 100ml inj , dexamethasone sodium phosphate 4 dot 4 mg equivalent to dexamethasone phosphate 4 mg per ml 2 ml inj , dextrose 50 percent 25 ml inj , dextrose inj 25 percent 25 ml inj , diazepam 10 mg 2 ml inj , diclofenac 25 mg per ml ip 3 ml inj , dicyclomine hcl 20mg inj , dulaglutide 0 dot 75 mg solution for inj in pre filled pen , dulaglutide 1 dot 5 mg solution for inj in pre filled pen , erythropoeitin human recombinant 2000 iu , etophylline bp 84 dot 7 mg and theophylline ip 25 dot 3 mg per ml 2 ml inj , frusemide 20 mg 2 ml inj , gentamycin sulphate inj im per iv 40mg per ml 2 ml inj , glulisine 100 u per ml inj apidra , haloperidol decanoate 50 mg per ml inj in 1ml amp , inj levocarnitine 1 gm per 5ml , insulin biphasic aspart protamine 50 per 50 novomix 50 , insulin glargine 450 iu per 1 dot 5 ml , insulin highly purified human neutral 40 iu per ml 10 ml inj , insulin lispro biphasicinjection insulin lispro 50 percent insulin lispro protamine suspension humalog mix50 per 50 inj , insulin nph 40 iu per 10 ml inj , iron sucrose 100mg 5ml inj , lignocaine 2 percent pf preservation free inj , multi vit inj iv 2 dash 10ml with minimum constituents having thiamine b1 dash 30mg per ml pyridoxine b6 30mg per ml and b12 cyanocobalamin dash 300mcg per ml , pheniramine maleate inj 22 dot 75 mg per ml amp of 2 ml , ranitidine hcl 50 mg 2 ml inj , tranexamic acid 500 mg per 5ml inj , triamcinolone acetate 10 mg per ml inj , zoledronic acid 4 mg inj , zoledronic acid 5 mg inj , influenza vaccine , metronidazole inj for iv use containing 500mg per bott of 100 ml , inj denosumab 60mg , tab daralutamide 300 mg //bid details 2 / 35
Tender For supply of acamprosate gastro-resistant tablets , adapalene , adenine , bedaquiline fumarate , bepotastine besilate , calcium folinate tablets , calcium polystyrene sulphonate , cefprozil , dactinomycin or dactinomycin for injection , dapagliflozin or dapagliflozin and metforminhydrochloride prolonged-release tablets , dapagliflozin propanediol monohydrate , desloratadine or desloratadine tablets , entecavir oral solution , eribulin mesylate , eribulin mesylate or eribulin injection , etravirine or etravirine tablets , fulvestrant injection , low-substituted hydroxypropyl cellulose , iohexol or iohexol injection , micafungin sodium , minocycline hydrochloride or cap or inj or tab , morphine prolonged-release tablets , oxytocin concentrated solution , phytomenadione tablets , pilocarpine hydrochloride or pilocarpine hydrochloride eye drops , pilocarpine hydrochloride eye drops , pomalidomide or cap , proparacaine hydrochloride or proparacaine eye drops , acamprosate impurity a , acetylcysteine impurity a , acetylcysteine impurity b , acetylcysteine impurity c , acetylcysteine impurity d , adapalene impurity c , adapalene impurity a , adapalene impurity d , bedaquiline impurity b , bepotastine besilate r-isomer impurity , bepotastine impurity a , amoxycillin related compound i , cefprozil related compound d , celecoxib impurity a , celecoxib impurity b , clarithromycin identity , clindamycin impurity e , clindamycin impurity f , clindamycin impurity g , clindamycin impurity i , clindamycin impurity j , clindamycin impurity k , clindamycin impurity b , clindamycin impurity l , ortho isomer of dapagliflozin impurity , dapagliflozin dimer-1 , dapagliflozin impurity a , dapagliflozin impurity b , desloratadine related compound b , desloratadine related compound a , desloratadine related compound f , 5-chloro-2-methylaminobenzophenone , 3- amino-6-chloro-1-methyl-4-phenylquinolin-2-ol , eribulin impurity c , etravirine system suitability mixture , frusemide related compound b , fulvestrant impurity a , galantamine hydrobromide related compound mixture , iohexol related compound b , iohexol related compound a , iohexol related compound c , micafuin epimer , minocycline impurity a , minocycline impurity b , minocycline impurity c , minocycline impurity e , minocycline impurity f , minocycline impurity g , minocycline impurity h , morphine impurity f , pilocarpine impurity a , 3-amino-4- propoxybenzoic acid